[ad_1]
Lieff Cabraser Heimann & Bernstein, LLP Law Firm Announces Has filed a class action lawsuit on behalf of investors who purchased or otherwise acquired Athira Pharma, Inc. securities. (“Athira” or “Company”) (NASDAQ:Atta) September 18, 2020 to June 17, 2021 (“Class Action Period”), including purchases based on or traceable to the registration statement and prospectus related to the company’s September 2020 initial public offering (“IPO”) Athira common stock.
If you purchase or otherwise acquire Athira securities during the class action and/or IPO, you can request the court to appoint the lead plaintiff no later than August 24, 2021. Other class members direct the litigation. Any share of your recovery in the litigation will not be affected by your decision whether to seek appointment as the lead plaintiff. You can hire Lieff Cabraser or another lawyer as your litigation lawyer.
Athira investors who wish to learn more about the litigation and how to seek to be appointed as lead plaintiff should click here Or call toll free 1-800-541-7358 to contact Sharon M. Lee of Lieff Cabraser.
The background of Athira Securities…
The full story on Benzinga.com
[ad_2]
Source link
